Opinion statement
Nervous system metastases occur in about 25% of patients with systemic cancer (Table 1) and usually involve the brain parenchyma, leptomeninges, and spinal epidural space. Although they are ominous, they can be effectively treated in many patients, reducing disability and prolonging life. Treatment may include surgery, and radiation therapy and chemotherapy are often necessary. The choice of agents is often made on the basis of the primary tumor. Even when sustained remission cannot be achieved, effective palliation can be accomplished in most patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Posner JB: Neurologic Complications of Cancer. Philadelphia: F.A. Davis; 1995.
Freilich RJ, Seidman AD, DeAngelis LM: Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 1995, 76:232–236.
DeAngelis LM: Management of brain metastases. Cancer Invest 1994, 12:156–165.
Jayson GC, Howell A: Carcinomatous meningitis in solid tumours. Ann Oncol 1996, 7:773–786.
Jorda M, Ganjei-Azar P, Nadji M: Cytologic characteristics of meningeal carcinomatosis. Arch Neurol 1998, 55:181–184.
Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995, 38:51–57.
Glantz MJ, Cole BF, Friedberg MH, et al.: A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996, 46:985–991.
Weaver S, Forsyth P, Fulton D, et al.: A prospective randomized study of prophylactic anticonvulsants (AC) in patients with primary brain tumors (PBT) or metastatic brain tumors (MBT) and without prior seizures (Sz): a preliminary analysis of 67 patients [abstract]. Neurology 1995, 45:A263.
Fetell MR, Grossman SA, Fisher JD, et al.: Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. J Clin Oncol 1997, 15:3121–3128.
Glantz MJ, Cole BF, Recht L, et al.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561–1567. This article highlights the potential usefulness of systemic chemotherapy for leptomeningeal metastases and the potential superiority of systemic chemotherapy over intrathecal drug administration.
Wong ET, Portlock CS, O’Brien JP, DeAngelis LM: Chemosensitive epidural spinal cord disease in non-Hodgkin’s lymphoma. Neurology 1996, 46:1543–1547. This study shows that epidural metastases can be treated effectively with systemic chemotherapy in certain circumstances.
Buckner JC: The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Cancer Metastasis Rev 1991, 10:335–341.
Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.
Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583–590.
PatchellRA, Tibbs PA, Regine WF, et al.: Postoperative radiotherapy in the treatment of single metastases to the brain. A randomized trial. JAMA 1998, 280:1485–1489. This randomized prospective trial clearly shows that whole-brain radiation therapy significantly decreases intracranial relapse after complete resection of a single brain metastasis. Although the frequency of neurologic death was reduced, overall survival did not improve because patients died of systemic cancer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeAngelis, L.M. Metastatic disease of the nervous system. Curr Treat Options Neurol 1, 409–416 (1999). https://doi.org/10.1007/s11940-996-0004-z
Issue Date:
DOI: https://doi.org/10.1007/s11940-996-0004-z